Improved total synthesis of the antibiotic A54145B.

A54145B is a calcium-dependent cyclic lipodepsipeptide antibiotic that is active against Gram-positive pathogens. Herein, we report an improved synthetic route toward A54145B in terms of the yield and time required. The key changes include using a pre-assembled minimalist tetradepsipeptide building block to solve the difficult on-resin esterification from our previous synthetic route, and a new macrocyclization site to avoid the peptide self-cleavage problem.

[1]  Xuefu You,et al.  Methylation of Daptomycin Leading to the Discovery of Kynomycin, a Cyclic Lipodepsipeptide Active Against Resistant Pathogens. , 2020, Journal of medicinal chemistry.

[2]  Scott D. Taylor,et al.  Total Synthesis of Analogs of A54145D and A54145A1 for Structure-Activity Relationship Studies. , 2019, The Journal of organic chemistry.

[3]  Sung‐Hyun Yang,et al.  A versatile Boc solid phase synthesis of daptomycin and analogues using site specific, on-resin ozonolysis to install the kynurenine residue. , 2019, Chemistry.

[4]  Scott D. Taylor,et al.  Total Synthesis of A54145 Factor D. , 2019, The Journal of organic chemistry.

[5]  Xuechen Li,et al.  Total Synthesis and Structural Establishment/Revision of Antibiotics A54145. , 2019, Organic letters.

[6]  Han Liu,et al.  Development of aspartic acid ligation for peptide cyclization derived from serine/threonine ligation , 2018, Chinese Chemical Letters.

[7]  Xuechen Li,et al.  Structure-activity relationship of daptomycin analogues with substitution at (2S, 3R) 3-methyl glutamic acid position. , 2017, Bioorganic & medicinal chemistry letters.

[8]  T. Poulsen,et al.  Ester coupling reactions--an enduring challenge in the chemical synthesis of bioactive natural products. , 2015, Natural product reports.

[9]  Scott D. Taylor,et al.  Solid-phase total synthesis of daptomycin and analogs. , 2015, Organic letters.

[10]  Davy Sinnaeve,et al.  Rapid total synthesis of cyclic lipodepsipeptides as a premise to investigate their self-assembly and biological activity. , 2014, Chemistry.

[11]  Han Liu,et al.  Total synthesis of daptomycin by cyclization via a chemoselective serine ligation. , 2013, Journal of the American Chemical Society.

[12]  Richard H. Baltz,et al.  Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved Properties , 2010, Antimicrobial Agents and Chemotherapy.

[13]  F. Kopp,et al.  Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145. , 2006, Biochemistry.

[14]  Li-he Zhang,et al.  New One-Carbon Degradative Transformation of β-Alkyl-β-azido Alcohols , 2006 .

[15]  F. Albericio,et al.  p‐Nitrobenzyloxycarbonyl (pNZ) as a Temporary Nα‐Protecting Group in Orthogonal Solid‐Phase Peptide Synthesis – Avoiding Diketopiperazine and Aspartimide Formation , 2005 .

[16]  L. Mortin,et al.  Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. , 2005, The Journal of infectious diseases.

[17]  M. Larkin.  Daptomycin approved for skin and skin-structure infections , 2003 .

[18]  J. Pelletier,et al.  Improved Solid-Phase Peptide Synthesis Method Utilizing α-Azide-Protected Amino Acids , 2001 .

[19]  P. Baker,et al.  A54145, a new lipopeptide antibiotic complex: isolation and characterization. , 1990, The Journal of antibiotics.

[20]  F. T. Counter,et al.  A54145 a new lipopeptide antibiotic complex: microbiological evaluation. , 1990, The Journal of antibiotics.

[21]  F. Albericio,et al.  Use of Oxyma as pH modulatory agent to be used in the prevention of base‐driven side reactions and its effect on 2‐chlorotrityl chloride resin , 2012, Biopolymers.

[22]  J. Vilarrasa,et al.  A fast procedure for the reduction of azides and nitro compounds based on the reducing ability of Sn(SR)3-species , 1990 .